Key result
Intravenous tolbutamide and glibornuride produced no significant changes in systolic time intervals, heart rate, or blood pressure, indicating no acute positive inotropic action.
Why the study?
Do intravenous tolbutamide and glibornuride affect systolic time intervals in healthy volunteers?
Do intravenous tolbutamide and glibornuride affect systolic time intervals in healthy volunteers?
Intravenous tolbutamide and glibornuride do not exhibit acute positive inotropic action in healthy volunteers.
Answers are grounded in this paper and cite their sources.
No acute inotropic effects seen in healthy volunteers; leaves open any chronic cardiac actions in diabetes.
The acute effects of therapeutic doses of intravenous tolbutamide and glibornuride on the systolic time intervals (QS2c, LVETc, PEPc and PEP/LVET) were examined in 5 healthy volunteers. Blood sugar was maintained constant throughout the study. No significant changes of these intervals as well as of heart rate and blood pressure were observed. Therefore, it is concluded that tolbutamide and glibornuride have no acute positive inotropic action.
No takes yet. Share an insight, caveat, or question.
Dubach et al. (2008) studied Healthy volunteers (n=5). Intravenous tolbutamide and glibornuride was evaluated on Systolic time intervals (QS2c, LVETc, PEPc and PEP/LVET). Intravenous tolbutamide and glibornuride produced no significant changes in systolic time intervals, heart rate, or blood pressure, indicating no acute positive inotropic action.
Synapse has enriched 10 related papers. Consider them for comparative context: